Hospital Acquired Infections Therapeutic Market

Mar 2021| MRS109A| Market Research Studies

Report Highlights

The scope of this report is broad and covers different types of Hospital Acquired Infections on the basis of drugs and infection type, along with the different modes of transmission of the hospital acquired infections. The market is broken down by infection types, drug class, mode of transmission, source, and regional markets. The revenue forecasts from 2020 to 2026 are given for each major type of infection types, drug class, mode of transmission, source, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional hospital acquired infections markets; it explains the major market drivers of the Global Hospital Acquired Infections Therapeutic industry, current trends within the industry, major applications and the regional dynamics of the Global Hospital Acquired Infections Therapeutic Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Hospital Acquired Infections Therapeutic Market.

Report Includes

  • 49 tables and 56 figures
  • An up-to-date analysis of the Global Hospital Acquired Infections Therapeutic Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Hospital Acquired Infections Therapeutic Market, and corresponding market share analysis by Infection Type, Drug Class, Mode of Transmission, Source, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Hospital Acquired Infections Therapeutic, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new therapies and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Hospital Acquired Infections Therapeutic Market as compared to overall global economy.
  • Insight into the growth development strategies of major Hospital Acquired Infections Therapeutic manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Abbott Laboratories, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline Plc., AbbVie Inc., and many others.

Summary

Hospital Acquired Infections are the infections which are acquired by the patient during their visit or stay at the hospital. The market for Hospital Acquired Infections Therapeutic is expected to grow, mainly due to increasing prevalence of chronic diseases and hospital acquired infections. New product and therapy launch in the Asia-Pacific region, North America and Europe are also going to bolster the Global Hospital Acquired Infections Therapeutic Market.

Hospital Acquired Infections Therapeutic are mainly caused by antiviral, antifungal, and antibacterial drugs. The market is also segmented on the basis of infection types. On the basis of infection types, the market is sub-segmented under surgical site infections, urinary tract infections, ventilator-associated pneumonia, central line-associated bloodstream infection and many others. Furthermore, on the basis of mode of transmission, the market is segmented into direct or indirect contact, vector borne, air borne and water droplet. The Hospital Acquired Infections can be originated based on different sources such as, endogenous, exogenous and cross-infection.

The Global Hospital Acquired Infections Therapeutic Market will grow from over $9.86 billion in 2020 to $13.2 billion by 2027 at a CAGR of 3.5%.

  • Table 1 : Global Hospital Acquired Infections Therapeutic Market, Through 2026
  • Table 2 : Global Hospital Acquired Infections Therapeutic Market, by Infection Type, Through 2026
  • Table 3 : Global Hospital Acquired Infections Therapeutic Market, by Drug Class, Through 2026
  • Table 4 : Global Hospital Acquired Infections Therapeutic Market, by Mode of Transmission, Through 2026
  • Table 5 : Global Hospital Acquired Infections Therapeutic Market, by Source, Through 2026
  • Table 6 : Global Hospital Acquired Infections Therapeutic Market, by Region, Through 2026
  • Table 7 : Global Health Expenditures, by Country 2019-2020
  • Table 8 : North America Hospital Acquired Infections Therapeutic Market, by Infection Type, Through 2026
  • Table 9 : North America Hospital Acquired Infections Therapeutic Market, by Drug Class, Through 2026
  • Table 10 : North America Hospital Acquired Infections Therapeutic Market, by Mode of Transmission, Through 2026
  • Table 11 : North America Hospital Acquired Infections Therapeutic Market, by Source, Through 2026
  • Table 12 : North America Hospital Acquired Infections Therapeutic Market, by Country, Through 2026
  • Table 13 : Europe Hospital Acquired Infections Therapeutic Market, by Infection Type, Through 2026
  • Table 14 : Europe Hospital Acquired Infections Therapeutic Market, by Drug Class, Through 2026
  • Table 15 : Europe Hospital Acquired Infections Therapeutic Market, by Mode of Transmission, Through 2026
  • Table 16 : Europe Hospital Acquired Infections Therapeutic Market, by Source, Through 2026
  • Table 17 : Europe Hospital Acquired Infections Therapeutic Market, by Country, Through 2026
  • Table 18 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Infection Type, Through 2026
  • Table 19 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Drug Class, Through 2026
  • Table 20 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Mode of Transmission, Through 2026
  • Table 21 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Source, Through 2026
  • Table 22 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Country, Through 2026
  • Table 23 : South America Hospital Acquired Infections Therapeutic Market, by Infection Type, Through 2026
  • Table 24 : South America Hospital Acquired Infections Therapeutic Market, by Drug Class, Through 2026
  • Table 25 : South America Hospital Acquired Infections Therapeutic Market, by Mode of Transmission, Through 2026
  • Table 26 : South America Hospital Acquired Infections Therapeutic Market, by Source, Through 2026
  • Table 27 : South America Hospital Acquired Infections Therapeutic Market, by Country, Through 2026
  • Table 28 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Infection Type, Through 2026
  • Table 29 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Drug Class, Through 2026
  • Table 30 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Mode of Transmission, Through 2026
  • Table 31 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Source, Through 2026
  • Table 32 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Country, Through 2026
  • Table 33 : Abbott Laboratories: Financial Performance, Through 2020
  • Table 34 : Merck & Co., Inc.: Financial Performance, Through 2020
  • Table 35 : Pfizer Inc.: Financial Performance, Through 2020
  • Table 36 : GlaxoSmithKline Plc: Financial Performance, Through 2020
  • Table 37 : Bayer AG: Financial Performance, Through 2020
  • Table 38 : AbbVie Inc.: Financial Performance, Through 2020
  • Table 39 : F. Hoffmann-La Roche AG: Financial Performance, Through 2020
  • Table 40 : Daiichi Sankyo Company, Limited: Financial Performance, Through 2020
  • Table 41 : Allergan Plc: Financial Performance, Through 2020
  • Table 42 : Zimmer Biomet Holdings, Inc.: Financial Performance, Through 2020
  • Table 43 : AstraZeneca Plc: Financial Performance, Through 2020
  • Table 44 : Johnson and Johnson Services, Inc.: Financial Performance, Through 2020
  • Table 45 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 46 : Novartis AG: Financial Performance, Through 2020
  • Table 47 : Bellerophon Therapeutics, Inc.: Financial Performance, Through 2020
  • Table 48 : Achilles Therapeutics Plc: Financial Performance, Through 2020
  • Table 49 : Bioquell Limited: Financial Performance, Through 2020
  • Figure 1 : Global Hospital Acquired Infections Therapeutic Market
  • Figure 2 : Global Hospital Acquired Infections Therapeutic Market, by Value, 2019-2026
  • Figure 3 : Global Hospital Acquired Infections Therapeutic Market, by Value, by Infection Type, 2019-2026
  • Figure 4 : Global Hospital Acquired Infections Therapeutic Market, by Value, by Drug Class, 2019-2026
  • Figure 5 : Global Hospital Acquired Infections Therapeutic Market, by Value, by Mode of Transmission, 2019-2026
  • Figure 6 : Global Hospital Acquired Infections Therapeutic Market, by Value, by Source, 2019-2026
  • Figure 7 : Global Hospital Acquired Infections Therapeutic Market, by Value, by Region, 2020
  • Figure 8 : Global Hospital Acquired Infections Therapeutic Market, by Value, by Company, 2020
  • Figure 9 : Global Hospital Acquired Infections Therapeutic Market, Product Map, 2020
  • Figure 10 : North America Hospital Acquired Infections Therapeutic Market, by Value, 2019-2026
  • Figure 11 : North America Hospital Acquired Infections Therapeutic Market, by Value, by Infection Type, 2019-2026
  • Figure 12 : North America Hospital Acquired Infections Therapeutic Market, by Value, by Drug Class, 2019-2026
  • Figure 13 : North America Hospital Acquired Infections Therapeutic Market, by Value, by Mode of Transmission, 2019-2026
  • Figure 14 : North America Hospital Acquired Infections Therapeutic Market, by Value, by Source, 2019-2026
  • Figure 15 : North America Hospital Acquired Infections Therapeutic Market, by Value, by Country, 2020
  • Figure 16 : Europe Hospital Acquired Infections Therapeutic Market, by Value, 2019-2026
  • Figure 17 : Europe Hospital Acquired Infections Therapeutic Market, by Value, by Infection Type, 2019-2026
  • Figure 18 : Europe Hospital Acquired Infections Therapeutic Market, by Value, by Drug Class, 2019-2026
  • Figure 19 : Europe Hospital Acquired Infections Therapeutic Market, by Value, by Mode of Transmission, 2019-2026
  • Figure 20 : Europe Hospital Acquired Infections Therapeutic Market, by Value, by Source, 2019-2026
  • Figure 21 : Europe Hospital Acquired Infections Therapeutic Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Value, by Infection Type, 2019-2026
  • Figure 24 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Value, by Drug Class, 2019-2026
  • Figure 25 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Value, by Mode of Transmission, 2019-2026
  • Figure 26 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Value, by Source, 2019-2026
  • Figure 27 : Asia-Pacific Hospital Acquired Infections Therapeutic Market, by Value, by Country, 2020
  • Figure 28 : South America Hospital Acquired Infections Therapeutic Market, by Value, 2019-2026
  • Figure 29 : South America Hospital Acquired Infections Therapeutic Market, by Value, by Infection Type, 2019-2026
  • Figure 30 : South America Hospital Acquired Infections Therapeutic Market, by Value, by Drug Class, 2019-2026
  • Figure 31 : South America Hospital Acquired Infections Therapeutic Market, by Value, by Mode of Transmission, 2019-2026
  • Figure 32 : South America Hospital Acquired Infections Therapeutic Market, by Value, by Source, 2019-2026
  • Figure 33 : South America Hospital Acquired Infections Therapeutic Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Value, by Infection Type, 2019-2026
  • Figure 36 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Value, by Drug Class, 2019-2026
  • Figure 37 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Value, by Mode of Transmission, 2019-2026
  • Figure 38 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Value, by Source, 2019-2026
  • Figure 39 : Middle East & Africa Hospital Acquired Infections Therapeutic Market, by Value, by Country, 2020
  • Figure 40 : Abbott Laboratories: Revenue Share, 2020
  • Figure 41 : Merck & Co., Inc.: Revenue Share, 2020
  • Figure 42 : Pfizer Inc.: Revenue Share, 2020
  • Figure 43 : GlaxoSmithKline Plc: Revenue Share, 2020
  • Figure 44 : Bayer AG: Revenue Share, 2020
  • Figure 45 : AbbVie Inc.: Revenue Share, 2020
  • Figure 46 : F. Hoffmann-La Roche AG: Revenue Share, 2020
  • Figure 47 : Daiichi Sankyo Company, Limited: Revenue Share, 2020
  • Figure 48 : Allergan Plc: Revenue Share, 2020
  • Figure 49 : Zimmer Biomet Holdings, Inc.: Revenue Share, 2020
  • Figure 50 : AstraZeneca Plc: Revenue Share, 2020
  • Figure 51 : Johnson and Johnson Services, Inc.: Revenue Share, 2020
  • Figure 52 : Sanofi S.A.: Revenue Share, 2020
  • Figure 53 : Novartis AG: Revenue Share, 2020
  • Figure 54 : Bellerophon Therapeutics, Inc.: Revenue Share, 2020
  • Figure 55 : Achilles Therapeutics Plc: Revenue Share, 2020
  • Figure 56 : Bioquell Limited: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report